2016 05 Mar
Over the past 25 years, gadolinium-based contrast agents (GBCA) have been recognised to have exceptional safety profiles with minimal side effects, as three researchers showed in their presentations at the European Congress of Radiology (ECR 2016) in Vienna. Dr. Richard Semelka of the Department of Radiology, University of North Carolina at Chapel... Read more
JOIN OUR MANAGEMENT COMMUNITY
Hologic Announces FDA Clearance of Aptima® Assay to Detect Herpes Simplex Virus 1 & 2
Hologic, Inc. (Nasdaq: HOLX) has announced that it has obtained FDA c... Read more
Philips Speeds Up Research and Biomarker Discovery with Major Upgrade
Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health techno... Read more
New Study Investigates the Clinical Utility of ORi™, Masimo Oxygen Reserve Index™
Masimo (NASDAQ: MASI) has announced the findings of an abstract presen Read more
Information integration and artificial intelligence for better diagnosis and therapy decisions
Research alliance between Siemens Healthineers and Fraunhofer MEVIS develops... Read more
Clinical Trials Demonstrate Benefits of iFR Compared to FFR
The DEFINE FLAIR and iFR Swedeheart studies establish that iFR offers a... Read more
Mark Holmshaw Appointed President and CEO of Toshiba Medical Systems Europe
Toshiba Medical has announced the appointment of Mark Holmshaw as the... Read more
John Ormiston Awarded the EuroPCR 2017 Ethica Award
The 2017 Ethica Award, the highest honour of the European cardiovascular... Read more
Primex Pharmaceuticals Appoints Jostein Davidsen and Angelo Colombo as Board Members
Swiss pharmaceutical group Primex Pharmaceuticals AG announces new board... Read more
ECRI Institute’s President and CEO Named Top Patient Safety Leader for Second Time
Jeffrey C. Lerner, PhD, president and chief executive officer of ECRI... Read more
New President of Sectra’s Secure Communications Business Area
Simo Pykälistö, currently CFO and Executive Vice President of Sectra AB... Read more
JOIN OUR MANAGEMENT COMMUNITY
JOIN OUR MANAGEMENT COMMUNITY